Home Shop Service Stellenangebote Newsletter Das Unternehmen Shopping cart English
Bücher | Biowissenschaften | Zell- u. Molekularbiologie | Handbook of Dendritic Cells | Inhaltsverzeichnis
Unsere Produkte
Bücher
 
Soeben erschienen
Titelsuche
Featured Sites
Zeitschriften
Wählen Sie Ihr Fachgebiet
 
Contents  
 
Volume 1  
Preface V
List of Contributors XXXIX
Part A Dendritic Cell Biology 1
1 Introduction to Some of the Issues and Mysteries Considered in this Book on Dendritic Cells
Ralph M. Steinman 		3
1.1 Dendritic Cells as a Distinct Hematopoietic Lineage 3
1.1.1 Chapters 1–16, the Life History of Dendritic Cells 3
1.1.2 Questions Concerning the Dendritic Cell Lineage 4
1.2 Control of Lymphocyte Responses by Dendritic Cells 4
1.2.1 Chapters 17–30, Initiation of Immunity 4
1.2.2 Questions Concerning Antigen Uptake, Processing and Presentation 5
1.2.3 Questions Concerning Dendritic Cell Maturation 5
1.3 Dendritic Cells in Disease Pathogenesis 6
1.3.1 Chapters 31–51, Dendritic Cells in Infectious and Other Diseases 6
1.3.2 Some Questions on the Roles of Dendritic Cells in Diseases 7
1.4 Dendritic Cells and the Design of Vaccines and New Therapies 7
1.4.1 Chapters 52–55, Dendritic Cells in Immunotherapy 7
1.4.2 Dendritic Cells and the Design of Vaccines against Infectious Diseases 8
References 9
I Dendritic Cell Development 13
2 Bone Marrow Progenitors of Dendritic and Natural Interferon-producing Cells
Markus G. Manz 		13
2.1 Hematopoietic Stem Cells and Successive Lineage-restricted Early Hematopoietic Progenitor Cells 14
2.2 Proposed Models for Dendritic and Natural Interferon-producing Cell Differentiation 15
2.3 Unexpected Redundancy in Dendritic and Natural Interferon-producing Cell Development from both Lymphoid and Myeloid Restricted Hematopoietic Progenitor Cells 16
2.4 Immediate Dendritic and Natural Interferon-producing Cell Precursors 17
2.5 Proposed ”flt3-license” Working Model for Steady-State Dendritic and Natural Interferon-producing Cell Development from Early Hematopoietic Progenitor Cells 18
2.6 Conclusions 20
Acknowledgement 21
References 21
3 Growth Factors
Herbert Strobl, Barbara Platzer, Almut Jörgl, Sabine Taschner, Leonhard Heinz and Peter Reisner 		27
3.1 Introduction 27
3.2 Short Description of Key Cytokines Involved in DC Development 28
3.2.1 Flt3 Ligand (FLT3L, FL) 28
3.2.2 GM-CSF (Granulocyte-macrophage Colony-stimulating Factor) 29
3.2.3 Interleukin 3 (IL-3) 30
3.2.4 Interleukin 4 (IL-4) 30
3.2.5 Interleukin-15 (IL-15) 31
3.2.6 TNFa (Tumor Necrosis Factor-alpha) 31
3.2.7 TGF-â1 (Transforming Growth Factor Beta-1) 32
3.3 Regulation of in vitro DC Hematopoiesis by Cooperating Cytokine Signals 33
3.3.1 Cytokines in the Induction and Amplification of CD1a+ Myeloid DC Subsets from Hematopoietic Progenitor Cells in vitro 33
3.3.2 Cytokines for Pre-expansion of Myeloid DC Progenitor Cells 35
3.3.3 Cytokine Combinations that Promote Myeloid DC Expansion Reciprocally Inhibit Plasmacytoid DC Development in Suspension Cultures 36
3.3.4 TGF-1 and its Essential Co-signals for LC Differentiation from Hematopoietic Progenitor/Stem Cells 39
3.3.5 TGF-1 Induces LC Differentiation from Monocyte Intermediates 40
3.3.6 Redundancy among Cytokine Signals Directing LC Differentiation from CD34+ Hematopoietic Progenitor Cells 41
3.3.7 TGF-1-dependent LC Induction by in vivo Occurring Candidate Precursors 41
3.3.8 Cytokines Promoting the Generation of Monocyte-derived DC 42
3.3.9 Evidence for Cellular Heterogeneity of DC Arising from CD34+ Progenitors or Monocytes 43
3.4 Conclusions 43
References 44
4 Transcription Factors: Deciphering the Transcription Factor Network of Dendritic Cell Development
Thomas Hieronymus and Martin Zenke 		53
4.1 Introduction 53
4.2 Ikaros 54
4.3 RelB 55
4.4 PU.1 56
4.5 C/EBPa 57
4.6 Pax5 60
4.7 IRF family 60
4.8 Id2 63
4.9 Runx3 64
4.10 Gfi1 64
4.11 Concluding Remarks 65
References 66
II Sentinel Dendritic Cells in Nonlymphoid Organs 73
5 Epidermal Langerhans Cells
Nikolaus Romani, Christoph H. Tripp, Gudrun Ratzinger, Christine Heufler, Franz Koch, Sem Saeland and Patrizia Stoitzner 		73
5.1 Introduction and Definition 73
5.2 A Short Review of the History of Langerhans Cells 73
5.3 Characterization and Morphology of Langerhans Cells 75
5.4 Entry of Langerhans Cells into the Epidermis in Ontogeny and Adulthood 76
5.4.1 Entry of Langerhans Cells into the Epidermis during Ontogeny 76
5.4.2 Entry and Turnover of Langerhans Cells into the Adult Epidermis under Homeostatic Conditions 77
5.4.3 Entry and Turnover of Langerhans Cells into the Adult Epidermis under Inflammatory Conditions 78
5.5 Lineage of Langerhans Cells 79
5.6 Langerhans Cells in Lymphoid Organs 80
5.7 Langerhans Cells as a Paradigm for Dendritic Cell Function 82
5.8 The Changing of the Paradigm 84
5.9 Can Langerhans Cells Induce Immunity in vivo? 85
5.10 Can Langerhans Cells maintain Peripheral Tolerance in vivo? 86
5.11 Can Langerhans Cells be Applied in Immunotherapy? 88
5.12 Recent Methodical Advances Relevant for the Study of Langerhans Cells 89
Acknowledgements 90
References 90
6 Characterization of Dendritic Cells and other Antigen-presenting Cells in the Eye
Joan Stein-Streilein 		101
6.1 Introduction 101
6.2 APC in Various Regions of the Eye 103
6.3 DC/APC in the Retina 103
6.4 DC/APC in the Cornea 105
6.5 DC/APC in the Anterior Chamber 105
6.6 Mechanisms of ACAID Induction in the Spleen 107
6.7 The Role of the F4/80 Protein in ACAID 109
6.8 Therapeutic Potential of ACAID APC 110
6.9 Conclusions and Implications 111
Acknowledgements 111
Abbreviations 112
References 112
7 Toll-like Receptors
Hubertus Hochrein and Hermann Wagner 		119
7.1 TLR and their Ligands 119
7.2 TLR Subfamilies 121
7.3 TLR and Dendritic Cell Subsets 122
7.4 TLR Signaling 123
7.5 What Determines the Outcome of the Immune Responses? 124
References 126
8 C-type Lectins on Dendritic Cells: Antigen Receptors and Modulators of Immune Responses
Yvette van Kooyk and Teunis B.H. Geijtenbeek 		129
8.1 Introduction 129
8.2 DCs and Antigen Recognition Receptors 130
8.3 CLRs as Antigen Receptors for Homeostatic Control 130
8.4 CLRs as Adhesion Receptors 131
8.5 CLRs as Pathogen Receptors 133
8.5.1 HIV-1 as Prototypic Example for Virus-DC-SIGN Interactions 133
8.6 Glycan Modifications and Pathogen Recognition by DCs 134
8.7 CLRs as Signaling Receptors 136
8.8 CLRs and Recognition of Cancer 137
8.9 Concluding Remarks 137
Abbreviations 138
Acknowledgements 138
References 139
9 Scavenger Receptors on Dendritic Cells
Emma J. McKenzie, Subhankar Mukhopadhyay, Siamon Gordon and Luisa Martinez-Pomares 		141
9.1 Introduction 141
9.2 Structure and Binding Properties of Mammalian Scavenger Receptors 142
9.2.1 Class A Scavenger Receptors 143
9.2.1.1 SR-A I,II and III (SR-A) 143
9.2.1.2 MARCO 144
9.2.1.3 SRCL-I 146
9.2.2 CD36 147
9.2.3 LOX-1 148
9.2.4 SREC-I 149
9.2.5 Other Members of the SR Family 149
9.2.5.1 CD68 149
9.2.5.2 SR-B1, FEEL-1 and FEEL-2 150
9.3 Role of Scavenger Receptors in Dendritic Cell Biology 150
9.3.1 SR and Antigen Internalization for Presentation to the Acquired Immune System 151
9.3.1.1 In vitro Generation of SR Ligands and its Effect in Immunogenicity 151
9.3.1.2 Crosspresentation of Ag Through Uptake of Apoptotic Cells 152
9.3.1.3 Crosspresentation of Ag Acquired through Live Cell Nibbling 153
9.3.1.4 Crosspresentation of Peptide-chaperone Complexes 153
9.3.2 Role of SR in the Modulation of Dendritic Cell Activation 155
9.3.2.1 Role of SR in Modulation of Dendritic Cell Phenotype in Response to Uptake of Apoptotic Cells 155
9.3.2.2 Role of SR in Modulation of Dendritic Cell Phenotype in Response to Uptake of Necrotic Cells 155
9.3.2.3 Cross-talk between SR and Toll-like Receptors 156
9.4 Concluding Remarks 156
References 157
10 Production of the Long Pentraxin PTX3 by Myeloid Dendritic Cells: Linking Cellular and Humoral Innate Immunity
Paola Allavena, Barbara Bottazzi, Andrea Doni, Luigina Romani, Cecilia Garlanda and Alberto Mantovani 		165
10.1 Introduction 165
10.2 The Pentraxin Superfamily and the Prototypic Long PTX3: Molecules and Ligands 165
10.3 Myeloid DC as a Major Source of PTX3: Regulation of Production 168
10.4 Blood-circulating Myeloid, but not Plasmacytoid, DC Produce PTX3 169
10.5 Role of PTX3 in Innate Immunity 170
10.6 Function of Antigen Presenting Cells in PTX3-deficient Mice 170
10.7 Conclusion 171
References 172
11 Gene Profiling of Dendritic cells during Host–Pathogen Interactions
Maria Foti, Francesca Granucci, Mattia Pelizzola, Norman Pavelka, Ottavio Beretta, Caterina Vizzardelli, Matteo Urbano, Ivan Zanoni, Giusy Capuano, Francesca Mingozzi, François Trottein, Toni Aebischer and Paola Ricciardi-Castagnoli 		175
11.1 Dendritic Cells as Sentinels of the Immune System: Tissue-resident DC and Migratory DC 175
11.2 Study of the Complexity of the Immune System using Gene Profiling 177
11.3 Discovery of IL2 Production by DC using Global Technologies and the NK-DC Interplay 179
11.4 Profiling of Pathogens and Cells of the Innate Response: Mucosal Epithelial Cells, Phagocytic Cells (Neutrophils and Macrophages) 180
11.5 Dendritic Cells and Pathogen Interaction: Dendritic Cells as a Link between Innate and Acquired Immunity 182
11.6 Dendritic Cells as Sensors of Infection 184
11.7 DC Transcriptional Profile Induced by Pathogen Teaches the Dynamic of the Interactions: DC Transcriptome; Core and Specific Responses 185
11.8 DC and Shistosoma Mansoni Specific Signature 186
11.9 DC and Leishmania Mexicana: Molecular Profile of the Interaction 190
11.10 Conclusions 192
References 192
III Dendritic Cells in Secondary Lymphoid Organs 199
12 Dendritic Cell Subtypes
Ken Shortman and Jóse A. Villadangos 		199
12.1 Introduction 199
12.2 DC Surface Antigen Heterogeneity and the Recognition of DC Subtypes 201
12.3 DC Subtypes in Steady-state versus Infected Mice 202
12.4 Extraction and Enrichment of DC from Lymphoid Tissue 203
12.5 Plasmacytoid versus Conventional DC 203
12.6 Spleen DC Subtypes 204
12.7 Lymph Node DC Subtypes 206
12.8 Thymic DC 208
12.9 The Maturation State of Lymphoid Organ DC Subtypes 209
12.10 Generation and Lifespan of DC Subtypes 210
12.11 Human DC Subtypes 211
12.12 Functional Differences between DC Subtypes 212
References 212
IV Circulating Dendritic Cells and their Precursors 219
13 pDC: From Plasmacytoid Dendritic Cell Precursors to Professional Type 1 Interferon-producing Cells
Yong-Jun Liu, Holger Kanzler, Yui-Hsi Wang, Yi-Hong Wang, Michel Gilliet, Wei Cao and Tomoki Ito 		219
13.1 Introduction 219
13.1.1 A Mysterious Cell Type with Plasmacytoid Morphology 219
13.1.2 A Mysterious Cell Type that has the Capacity to Produce Huge Amounts of Type 1 IFNs 221
13.1.3 From pDC to IPC 221
13.1.4 pDCs/IPCs in Mice, Rat, Pig, and Monkey 222
13.2 Isolation and Characterization of pDCs/IPCs 222
13.2.1 Isolation of Human pDCs/IPCs 222
13.2.2 Isolation of Mouse pDCs/IPCs 222
13.2.3 pDC/IPC Morphology 223
13.2.4 Surface Phenotype of pDCs/IPCs 224
13.3 pDC/IPC Development 224
13.4 Localization, Migration, and Lifespan of pDCs/IPCs 227
13.5 Innate Immune Response by pDCs/IPCs 228
13.5.1 pDCs/IPCs Selectively Express Intracellular TLR-7 and TLR-9 that Respectively Recognize Single-Stranded RNA and Double-Stranded DNA 228
13.5.2 pDCs/IPCs Are Professional Type 1 IFN-Producing Cells 229
13.5.3 pDCs/IPCs Rapidly Produce Large Amounts of IFN-a that Is Independent of Positive Feedback of IFN-â Through Type 1 IFN Receptors 230
13.5.4 TLR7/TLR9-mediated IFN-a production by pDCs/IPCs depends on Myd88-IRAK4-TRAF6-IRF-7 complexes 231
13.5.5 Human pDCs/IPCs Have a Limited Ability to Produce IL-12 231
13.5.6 Myeloid DCs Are Specialized in Producing IL-12, but not Type 1 IFNs 233
13.6 Regulation of T-cell-mediated Immune Responses by pDCs/IPCs 233
13.6.1 pDC/IPC Differentiation to Mature DCs through Two Pathways 233
13.6.2 pDC-Derived DCs Induce Th1 by IFN- but not IL-12 235
13.6.3 pDC-Derived DCs Induce Th2 through OX40L 235
13.6.4 pDC-Derived DCs and their Ability to Prime Naïve versus Memory T Cells 235
13.6.5 pDC-Derived DCs and Presentation of Endogenous and Exogenous Antigens 235
13.6.6 pDCs/IPCs and Cross-priming 236
13.6.7 pDCs/IPCs and Regulatory T Cells 236
13.7 pDCs/IPCs Regulate the Function of Conventional Myeloid DC by Type 1 IFN 237
13.8 Regulation of NK Cell Function by pDCs/IPCs 238
13.9 Regulation of B-cell Function by pDCs/IPCs 239
13.10 pDCs/IPCs and Human Diseases 239
13.10.1 HIV 239
13.10.2 Systemic Lupus Erythematosus (SLE) 239
13.10.3 Cancer 240
13.11 Conclusion 240
Acknowledgments 241
References 241
14 Monocyte subsets and their relation to DCs
Brigitte Senechal, Darin Fogg, Gaelle Elain, and Frederic Geissmann 		253
14.1 Monocytes and the Concept of the ”Mononuclear Phagocyte System” (MPS) 254
14.1.1 Blood Monocytes in the Mononuclear Phagocyte System 254
14.1.2 Plasticity of Monocytes as Studied in vitro and its Relevance to DC Differentiation in vivo 256
14.1.3 Contribution of Monocytes to Long-lived Resident Cells in Peripheral Tissues 257
14.1.4 Contribution of Monocytes to Short-lived Bone Marrow-derived Steady State Macrophages and DC 258
14.1.5 Evidence that Monocytes Contribute to Short-lived Migrating Dendritic Cells that Differentiate During Inflammation and Infection 259
14.1.6 Summary of the Respective Contribution of Monocytes to Individual Subsets of the MPS System 260
14.2 Molecular Determinants of Monocyte Differentiation 260
14.3.2 Monocyte Subsets 262
14.3.3 CCR2+ CX3CR1low ”Inflammatory” Monocytes 264
14.3.4 The Enigmatic CCR2- CX3CR1high Monocytes 265
14.3.5 Relationship Between CCR2+ CX3CR1low Monocytes and CCR2- CX3CR1high Monocytes 266
14.3.6 Additional Subsets of Monocytes? 266
14.4 Migration of Monocytes and Their Recruitment to Tissues 267
14.4.1 Monocyte Entry into the Target Tissues 267
14.4.2 Baseline Extravasation of Monocytes 268
14.4.3 Recruiment of Monocytes During Inflammation and Infection 268
14.5 Concluding remarks 269
Acknowledgments 270
References 270
V Dendritic Cell Migration 279
15 Steady State Migration of Dendritic Cells in Lymph
Gordon MacPherson, Simon Milling, Emma Turnbull and Ulf Yrlid 		279
15.1 Introduction 279
15.1.1 Dendritic Cells 279
15.1.2 Why Study Lymph Dendritic Cells? 280
15.1.3 Lymphatic Terminology 280
15.1.4 Historical 281
15.2 Dendritic Cells in the Periphery 281
15.2.1 Constitutive Migration of Dendritic Cells from Peripheral Tissues 281
15.2.2 Exit of Dendritic Cells from Peripheral Tissues 282
15.2.3 Entry of Dendritic Cells into Peripheral Lymph 282
15.3 Lymph Dendritic Cells 282
15.3.1 Pseudo-afferent Lymph 282
15.4 Properties of Lymph Dendritic Cells in the Rat 283
15.4.1 Steady-state Output 283
15.4.2 Origin of Afferent Lymph Dendritic Cells 283
15.4.3 Steady-state Rat Lymph Dendritic Cells are ”Semi-mature” 284
15.4.4 Subsets of Rat Lymph Dendritic Cells 284
15.4.5 Migratory Fate of Lymph Dendritic Cells 285
15.4.6 Uptake and Transport of Apoptotic Cells by Intestinal Dendritic Cells 286
15.5 Dendritic Cells and B Cells 286
15.6 Dendritic Cells and the Pathogenesis of Transmissible Spongiform Encephalopathies (TSE) 287
15.7 Conclusions 288
References 288
16 Multiple Pathways to Control DC Migration
Karel Otero, Elena Riboldi, Annalisa Del Prete, Annunciata Vecchi, Fabio Facchetti, Alberto Mantovani and Silvano Sozzani 		295
16.1 Dendritic Cells as Professional Migratory Cells 295
16.2 Role of Chemokines in the Recruitment of Myeloid and Plasmacytoid Dendritic Cells 296
16.3 Migration of Mature Dendritic Cells to Secondary Lymphoid Organs 298
16.4 Chemotactic Factors for Dendritic Cells: more than Chemokines 301
16.5 Tuning Dendritic Cell Migration by Nonchemotactic Signals 303
16.6 Concluding Remarks 305
Acknowlegements 305
References 306
VI T-cell Activation and Co-stimulation 313
17 Antigen Processing and Presentation: CD1d and NKT cells
Serani L.H. van Dommelen, Dale I. Godfrey and Mark J. Smyth 		313
17.1 Introduction 313
17.2 CD1d and Antigen Presentation 313
17.2.1 The CD1d Molecule 313
17.2.2 Nature of CD1d and Glycolipid Recognition by TCR 315
17.2.3 Nature of CD1d-expressing APC 316
17.3 CD1d-restricted NKT Cells 318
17.3.1 Defining NKT Cells 318
17.3.2 Tissue Location and NKT Cell Subsets 319
17.4 Nature of the Antigens Presented by CD1d-expressing APC to NKT Cells 319
17.4.1 Self-ligands 320
17.4.2 Naturally-occurring Exogenous Ligands 320
17.4.3 Synthetic Ligands 321
17.5 Effector Functions of NKT Cells 321
17.5.1 Cytokine Secretion and Cytotoxicity of NKT Cells 322
17.5.2 The Initial Cross-talk Between CD1d-expressing APC and NKT Cells 322
17.5.3 Functional Diversity of NKT Cell Responses 323
17.5.4 Modulation of Downstream Immune Responses by a-GalCer-activated Cells 325
17.5.5 Adjuvant-like Effect of NKT Cells on DC Mediated Antigen Presentation 327
17.6 Role of CD1d-restricted NKT Cells in Disease Models 328
17.7 Conclusions 328
Acknowledgments 328
References 329
18 The Role of Dendritic Cells in T-cell Activation and Differentiation
Federica Sallusto and Antonio Lanzavecchia 		343
18.1 Introduction 343
18.2 Requirements for Activation of Naïve T Lymphocytes 343
18.2.1 Co-stimulatory and Inhibitory Pathways 345
18.2.2 Differentiation to Effector T Cells 345
18.3 Dendritic Cell Maturation 346
18.4 T-cell Priming by Dendritic Cells 347
18.4.1 Priming of Th1 and Inflammatory T-cell Responses 348
18.4.2 Priming of Th2 Cells 348
18.4.3 Imprinting Tissue Homing Receptors 349
18.4.4 The Role of Plasmacytoid Dendritic Cells in T-cell Responses 349
18.5 Concluding Remarks 350
References 350
19 Cytokines Produced by Dendritic Cells
David F. Tough 		355
19.1 Introduction 355
19.2 DC Cytokine Expression: A Few Caveats 355
19.3 Type I Interferon 356
19.4 IL-12, IL-23, IL-27 357
19.5 IL-18 359
19.6 IL-6 360
19.7 IL-1 360
19.8 TNF-a 362
19.9 Concluding Remarks 363
Acknowledgement 364
References 364
 
Volume 2  
VII Th1 and Th2 Decision 385
20 The Plasticity of Dendritic Cells Populations in Promoting Th-cell Responses
André Boonstra, Giorgio Trinchieri and Anne O’Garra 		385
20.1 Effector Th-cell Populations 385
20.2 Factors Inducing the Development of Th1 or Th2 Cells 386
20.2.1 The Strength of DC–Th-cell Interaction 387
20.2.2 Co-stimulators 388
20.2.3 Genetic Background 388
20.3 Opposing Concepts: Pre-programmed versus Flexible DC Direct Th-cell Development 388
20.3.1 Mouse Dendritic Cell Populations in Directing Th-cell Development 388
20.3.2 Human Dendritic Cell Populations in Directing Th-cell Development 390
20.4 Differential TLR Expression by Distinct Dendritic Cell Populations 392
20.4.1 Modulation of TLR Expression 392
20.5 Modulation of IL-12p70 or IFN- Production 393
20.6 Factors Responsible for Driving Th2-cell Development 395
20.7 Modulation by Tissue Factors 395
20.8 Concluding Remarks 396
References 397
21 Microbial Instruction of Dendritic Cells
Esther C. de Jong, Hermelijn H. Smits, Eddy A. Wierenga and Martien L. Kapsenberg 		405
21.1 Introduction 405
21.2 Effector Th1 and Th2 Cells and Regulatory T Cells 405
21.3 Dendritic Cells and Pattern Recognition Receptors 406
21.4 DC-derived Factors that Promote Th1, Th2 or Regulatory T-cell Responses 408
21.4.1 Th1 Cell-promoting Factors 408
21.4.2 Th2 Cell-promoting Factors 410
21.4.3 Regulatory T-cell-promoting Factors 410
21.5 TLR-mediated Activation of DC by Microbes and their Compounds 411
21.5.1 TLR2 411
21.5.2 TLR3 412
21.5.3 TLR4 412
21.5.4 TLR5 413
21.5.5 TLR7/8 413
21.5.6 TLR9 413
21.5.7 TLR10/11 414
21.6 Th1 Cell-promoting DC 414
21.7 Th2 Cell-promoting DC 415
21.8 Regulatory T-cell-promoting DC 415
21.9 Indirect Priming of DC 416
21.10 Concluding Remarks 417
References 417
VIII CTL Priming and Crosspresentation 427
22 Crossprocessing and Crosspresentation
Mojca koberne and Nina Bhardwaj 		427
22.1 Introduction 427
22.2 Acquisition of Antigens for Crosspresentation 428
22.2.1 Cells that Crosspresent 428
22.2.2 Sources of Antigens and Receptors involved in Crosspresentation 430
22.2.2.1 Apoptotic Cells 430
22.2.2.2 Necrotic Cells 432
22.2.2.3 Heat-shock Proteins 432
22.2.2.4 Immune Complexes 433
22.2.2.5 Nibbling from Live Cells 434
22.2.2.6 Exosomes 434
22.2.2.7 TLR and MyD88 involvement in Crosspresentation 435
22.3 Mechanisms of Crossprocessing and Crosspresentation 436
22.3.1 Entry into the Classical Endocytic Pathway 436
22.3.2 Phagosome–endosome Compartment 438
22.3.3 A Special Mechanism for Soluble Antigens? 439
22.3.4 Tap Dependence and Endocytic Exchange Mechanism (Vacuolar Pathway) 440
22.3.5 Transfer of Peptides via Gap Junctions 441
22.4 Physiological Relevance of Crosspresentation 442
Acknowledgements 442
References 443
23 A Systems Biologist’s View of Dendritic Cell–Cytotoxic T Lymphocyte Interaction
Burkhard Ludewig and Gennady Bocharov 		455
23.1 Introduction 455
23.2 Deciphering the Systems Biologist’s Approach 456
23.2.1 Modularity and Protocols 457
23.2.2 Feedback Control 458
23.2.3 Redundancy 460
23.2.4 Structural Stability 461
23.3 From Systems Biology to DC–CTL Immunobiology 461
23.3.1 Dynamics of CTL Activation and Differentiation 462
23.3.2 Multiple Levels of Positive and Negative Feedback Control 463
23.3.2.1 Managing DC Recruitment and Antigen Translocation 464
23.3.2.2 Elimination of DCs by Effector CTL 464
23.3.2.3 Rapid Amplification of Signals through Molecular ”Ping–Pong” Interactions 464
23.3.2.4 Limiting the CTL ”Overshoot” through Feedforward Control 465
23.3.3 DC Subsets Provide Redundant Activating Signals 466
23.3.4 Tuning of Dendritic Cell Activation 468
23.3.4.1 Excitement through Pattern Recognition 468
23.3.4.2 DC Tuning and Tolerance to Self-antigens 469
23.4 Conclusions 470
Acknowledgments 470
References 471
IX Dendritic Cells Cross-talk with Other Cell Types 481
24 Dendritic Cells and Natural Killer Cells
Magali Terme and Laurence Zitvogel 		481
24.1 Introduction on NK Cells 481
24.2 Activation of NK Cells by DC 482
24.2.1 NK-cell Activation and DC Subsets 483
24.2.2 Molecular Mechanisms of the DC-mediated NK-cell Activation 483
24.3 Reciprocal Interaction of DC and NK Cells 484
24.3.1 DC Maturation Induced by NK Cells 485
24.3.2 Lysis of DC by Activated NK Cells 485
24.4 Where do DC Meet NK Cells? 486
24.4.1 In Lymph Nodes 486
24.4.2 In the Periphery 487
24.5 DC/NK Cross-talk and T Lymphocytes 487
24.5.1 Bridging Innate and Adaptive Immunity 487
24.5.2 Modulation of the DC/NK-cell Cross-talk by CD4+CD25+ Regulatory T Cells and Conventional T Cells 489
24.6 The DC/NK-cell Cross-talk in Physiopathology 490
24.6.1 In Infectious Diseases 490
24.6.1.1 Viral Infections 490
24.6.1.2 Bacterial Infections 491
24.6.2 In Cancer 491
24.7 Concluding Remarks 493
References 494
25 Intercellular Communication via Protein Transfer
Marca H.M. Wauben 		499
25.1 What are Exosomes, and Where do they Come From? 499
25.2 Which Cells are Targets for Exosomes, and how do Exosomes Interact with these Cells? 500
25.3 What is the Consequence of Exosome Binding or Uptake for the Target Cell? 501
25.4 What is the Physiological Role of Exosomes in the Immune System? 502
25.5 Cell–Cell Contact-dependent Transfer of Membrane Proteins 504
25.6 How are Membrane Proteins Transferred Between Immune Cells, and What is their Fate? 506
25.7 What is the Physiological Role of Membrane Protein Swapping in the Immune System? 508
25.8 Concluding Remarks 509
Abbreviations 509
References 510
X Tolerogenic Dendritic Cells 517
26 Differentiation Stages and Subsets of Tolerogenic Dendritic Cells
Manfred B. Lutz 		517
26.1 Introductory Remarks 517
26.2 Mechanisms of T-cell Tolerance Induction 518
26.2.1 Ignorance 519
26.2.2 Anergy 519
26.2.3 Deletion 519
26.2.4 Immune Deviation 520
26.2.5 The Concept of ”Immune Balance” 520
26.2.6 Regulation/suppression 521
26.2.7 Combinations 521
26.3 Tolerogenic DC Subsets in vivo 522
26.3.1 Thymic DC 522
26.3.2 DC in Lymph Nodes and Spleen 523
26.3.3 Migratory DC from Peripheral Organs 523
26.3.4 Plasmacytoid DC 524
26.4 DC Precursors 524
26.5 Immature DC 525
26.5.1 Tissue Resident DC 525
26.5.2 Induction of T-cell Anergy by Immature DC 525
26.5.3 Maturation Inhibitors 526
26.5.4 Maturation Resistance 526
26.6 Semi-mature DC 528
26.6.1 Steady-state Migratory DC 530
26.7 Fully Mature DC 531
Acknowledgements 531
Abbreviations 531
References 532
27 Dendritic Cell Manipulation with Biological and Pharmacological Agents to Induce Regulatory T Cells
Luciano Adorini and Giuseppe Penna 		545
27.1 Introduction 545
27.2 Mechanisms Promoting Tolerogenic Dendritic Cells 546
27.2.1 Indoleamine 2,3-dioxygenase 547
27.2.2 Immunoglobulin-like Transcripts 547
27.3 Induction of Tolerogenic Dendritic Cells 548
27.3.1 Biological Agents Promoting Tolerogenic Dendritic Cells 549
27.3.1.1 IL-10 549
27.3.1.2 TGF- 550
27.3.1.3 TNF- 550
27.3.1.4 G-CSF 551
27.3.2 Pharmacological Agents Promoting Tolerogenic Dendritic Cells 551
27.4 Induction of Tolerogenic Dendritic Cells by VDR Agonists 553
27.4.1 Tolerogenic Dendritic Cells Induced by VDR Agonists lead to enhancement of regulatory T cells 555
27.4.2 Upregulation of Inibitory Receptor Expression in Dendritic Cells by VDR agonists 556
27.4.3 Modulation of Chemokine Production by VDR Agonists can affect Recruitment of Effector T cells and CD4+CD25+ Ts cells to Inflammatory Sites 557
27.5 Common Features of Agents Leading to Induction of Tolerogenic DCs 558
27.6 Conclusions 559
References 560
28 Surface Molecules Involved in the Induction of Tolerance by Dendritic Cells
Laura C. Bonifaz 		569
28.1 Introduction 569
28.2 Dendritic Cells and Central Tolerance 570
28.3 Dendritic Cells and Peripheral Tolerance 570
28.4 C-type Lectin Receptors 571
28.4.1 Advantages of DEC-205 as an Endocytic Receptor for Antigen Presentation 572
28.4.2 DEC-205: an Endocytic Receptor that Preserves the Steady State in the DC after the Capture of the Antigen 573
28.5 Induction of Peripheral Tolerance by Resting Dendritic Cells 573
28.5.1 The Same Dendritic Cells Could Operate in the Induction of Immunity 574
28.5.2 The Induction of Tolerance by Steady-state Dendritic Cells Promotes Avoidance of the Induction of Autoimmunity 574
28.5.3 Surface Molecules are Involved in Peripheral Tolerance Induction by Resting Dendritic Cells through DEC-205 575
28.5.4 Additional Evidence Supports the Role of Resting DC in the Induction of Peripheral Tolerance 575
28.6 Surface Molecules Involved in the Induction of Peripheral Tolerance 576
28.7 Other Receptors Involved in the Induction of Tolerance that can Preserve the Resting of DC or Induce Negative Signaling 577
28.7.1 Integrins 577
28.7.2 Fc Receptors 578
28.7.3 Suppressor and Regulatory T Cells 578
28.8 Notch Ligands as Surface Molecules Involved in the Induction of Regulatory T Cells 579
28.9 ILT-3 and ILT-4: Two Inhibitory Molecules Involved in Tolerance Induction 580
28.10 Special DC for Tolerance? 581
28.11 Regulatory–tolerogenic DC 582
28.12 Concluding Remarks 582
Acknowledgments 583
References 583
29 Interaction Between Dendritic Cells and Apoptotic Cells
Adriana T. Larregina and Adrian E. Morelli 		591
29.1 Introduction 591
29.2 Dendritic Cells Phagocytose and Process Apoptotic Cells 592
29.3 The Phagocytic Synapse 593
29.3.1 Externalized Phosphatidylserine (PS) and Receptors for PS 595
29.3.2 Thrombospondin-1 (TSP-1), CD36 and the Integrins v3 and v5 596
29.3.3 Complement Factors and Complement Receptors (CR) 596
29.3.4 Pentraxins 598
29.3.5 Milk-fat Globule Protein Epidermal Growth Factor 8 (MFG-E8)/lactadherin 598
29.3.6 Other Apoptotic Cell Recognition Signals 599
29.4 Redundant Receptors and Backup Mechanisms for Apoptotic Cell Clearance 600
29.5 Regulatory Effects of Early Apoptotic Cells on Dendritic Cells 600
29.6 Molecular Mechanisms of the Interaction between Dendritic Cells and Apoptotic Cells 602
29.7 Dendritic Cells, Apoptotic Cells and Peripheral Tolerance 603
29.8 The Potential Therapeutical Use of Apoptotic Cells for Peripheral Tolerance 605
29.9 Pathogens and Apoptotic Cell-like Mimicry 607
29.10 Dead Cells and the Delicate Balance between Immunity and Tolerance 608
29.11 Concluding Remarks 610
Acknowledgements 610
References 611
30 Pharmacologically Modified Dendritic Cells: A Route to Tolerance-associated Genes
Kathleen F. Nolan, Stephen F. Yates, Alison M. Paterson, Paul J. Fairchild and Herman Waldmann 		619
30.1 Dendritic Cells, Maturation and Tolerance 619
30.2 Gene Profiling 622
30.2.1 Gene Profiling Technologies 623
30.2.2 Serial Analysis of Gene Expression (SAGE) 624
30.2.2.1 SAGE Methodology 625
30.2.2.2 Handling Raw SAGE Data 627
30.2.3 Accumulation of a Comparative SAGE Resource for Identifying Tolerance-associated Genes 628
30.2.3.1 Relationship of Modulated DC Populations based on Gene Expression Patterns 631
30.2.3.2 Elucidation of ”Signatures” of Genes Associated with Tolerance 632
30.2.3.3 Identification of Novel Genes 634
30.2.3.4 AQ4 SAGE Library Comparisons Provide Insights to Biological Mechanism 634
30.3 Downstream Assessment of Tolerance Associated Candidate Genes 636
30.3.1 Simultaneous Assessment of Multiple Candidate Gene Expression Levels using a Custom ”Immunochip” 636
30.3.2 Assessing the Functional Relevance of Tolerance Candidates by Genetic Manipulation of DCs 637
30.3.3 Assessing the Functional Impact of Candidates in an in vivo Tolerance Model 638
30.4 Downstream Clinical Relevance 638
References 639
Part B Dendritic Cells in Disease 649
XI Parasites 651
31 Malaria
Britta C. Urban and Francis M. Ndungu 		651
31.1 Introduction to Malaria 651
31.2 Antigenic Variation 652
31.3 Animal Models for Malaria 653
31.4 Acquired Immunity to Malaria 653
31.4.1 Immune Response to Liver Stages 654
31.4.2 Cellular Immunity to the Erythrocytic Stage 654
31.4.3 Humoral Immunity to the Erythrocytic Stage 655
31.5 Immune Recognition of iRBC 656
31.5.1 Toll-like Receptors 656
31.5.2 CD36 657
31.5.3 Other Scavenger Receptors 658
31.5.4 Complement and Fc Receptors 658
31.6 Dendritic Cells in Malaria 658
31.6.1 DCs in Human Malaria 658
31.6.2 DCs in Rodent Malaria 659
31.7 Synopsis 660
Acknowledgments 662
References 663
32 Dendritic Cells in Leishmaniasis: Regulators of Immunity and Tools for New Immune Intervention Strategies
Heidrun Moll 		669
32.1 Introduction 669
32.2 Mechanisms Mediating Resistance or Susceptibility to Leishmaniasis 670
32.2.1 The Role of T Helper Cell Subsets 671
32.2.2 The Role of Regulatory T Cells 672
32.3 Dendritic Cell Interaction with Leishmania Parasites 673
32.3.1 Parasite Uptake by Dendritic Cells 673
32.3.2 Subcellular Location of Leishmania Parasites in Dendritic Cells 674
32.3.3 Dendritic Cell Subsets Involved in the Uptake of Leishmania 675
32.3.4 Dendritic Cells in Leishmania-infected Tissues 676
32.4 Dendritic Cell Migration and Induction of a Leishmania-specific Immune Response 676
32.4.1 The Role of Chemokines and Chemokine Receptors Expressed by Dendritic Cells 677
32.4.2 Transport and Presentation of L. major Antigen by Dendritic Cells 678
32.4.3 Parasite Persistence in Immune Hosts 680
32.5 Regulation of the Leishmania-specific Immune Response by Dendritic Cells 680
32.5.1 The Role of IL-12 Production by Dendritic Cells 681
32.5.2 Other Parameters that may Govern the Polarization of T Helper Cells 682
32.6 Parasite Evasion of Dendritic Cell Function 683
32.7 Dendritic Cells as Tools for Novel Immune Intervention Strategies Against Leishmaniasis 685
32.7.1 Dendritic Cell-based Vaccination and Immunotherapy 685
32.7.2 Parameters Determining the Efficacy of Dendritic Cell-based Immune Intervention Strategies 686
32.8 Conclusions and Perspectives 687
References 688
33 Sentinel and Regulatory Functions of Dendritic Cells in the Immune Response to Toxoplasma gondii
Alan Sher, Felix Yarovinsky, Romina Goldszmid, Julio Aliberti and Dragana Jankovic 		693
33.1 Introduction 693
33.2 Activation of DC by T. gondii 694
33.2.1 Responsive DC Subpopulations 694
33.2.2 Host Receptors and Parasite Ligands Involved in Triggering of Murine DC 696
33.2.3 Activation of Human DC 698
33.3 Regulation of DC Activity 699
33.4 Role of DC in T. gondii-induced Immune Polarization 700
33.5 Mechanisms of Antigen Presentation to T Cells 702
33.6 Towards an Understanding of DC Function in vivo 703
Acknowledgements 704
References 705
34 Schistosoma
Andrew S. MacDonald and Edward J. Pearce 		709
34.1 Introduction 709
34.2 DC Response to Schistosome Ag 710
34.3 Th2 Induction by DC in Response to Schistosome Ag 714
34.4 DC During Schistosome Infection 717
34.5 Discussion 718
Acknowledgements 719
References 719
XII Bacteria 723
35 Dendritic Cells and Immunity to Salmonella
Mary Jo Wick 		723
35.1 Introduction 723
35.2 Dendritic Cell Subsets, Short and Sweet 724
35.3 Dendritic Cells and Salmonella: Lessons from in vitro Studies 724
35.3.1 Bacterial Uptake and the Fate of Internalized Bacteria 724
35.3.2 Presentation of Salmonella Antigens by Dendritic Cells 727
35.3.2.1 Processing of Salmonella for Direct Presentation on MHC-II by Infected Dendritic Cells 727
35.3.2.2 Processing of Salmonella for Direct Presentation on MHC-I by Infected Dendritic Cells 727
35.3.2.3 Modulating of Antigen Presentation by Salmonella 728
35.3.2.4 Waste not, Want not: Dendritic Cells as Bystander Antigen-presenting Cells 729
35.4 Time to go to Work: Salmonella-induced Dendritic Cell Maturation 730
35.5 Murine Infection Models to Study Dendritic Cell Interaction with Salmonella in vivo 733
35.5.1 Salmonella Infection and Penetration of the Intestinal Epithelium 733
35.5.2 Dendritic Cell Take-up Salmonella in vivo 734
35.5.3 Getting the Game Started: Dendritic Cells Initiate Adaptive Immunity to Salmonella 734
35.5.3.1 Salmonella-induced Dendritic Cell Maturation During Infection 734
35.5.3.2 Presentation of Salmonella Antigens by Dendritic Cells in vivo 736
35.6 Concluding Remarks 737
Acknowledgements 737
References 738
36 Dendritic Cells in Tuberculosis
Ulrich E. Schaible and Florian Winau 		745
36.1 Introduction 745
36.2 Tuberculosis 745
36.3 Mycobacteria are Intracellular Pathogens 747
36.4 Dendritic Cells Present Antigens in Tuberculosis 749
36.5 Dendritic Cells are Regulatory Cells in Tuberculosis 752
36.6 Dendritic Cells and Cross-Priming 753
36.7 Mycobacteria Interfere with Antigen Presenting Cell Function 755
36.8 Conclusion 756
Acknowledgement 756
References 756
37 Dendritic Cell–Epithelial Cell Interactions in Response to Intestinal Bacteria
Maria Rescigno 		759
37.1 The Intestinal Epithelium and the Gut-associated Lymphoid Tissue (GALT) 759
37.2 Antigen Uptake in the Gut and DC Populations 760
37.3 Cross-talk between Bacteria and Epithelial Cells 762
37.4 Unique Functions of Mucosal DCs 763
37.5 Intestinal Immune Homeostasis is Regulated by the Cross-talk between ECs and DCs 764
37.6 Cross-talk between ECs and DCs in Bacterial Handling 766
37.7 Conclusions 767
References 767
 
Volume 3  
XIII Viruses 773
38 Sleeping with the Enemy: The Insidious Relationship between Dendritic Cells and Immunodeficiency Viruses
L. Vachot, S.G. Turville, S. Trapp, S. Peretti, G. Morrow, I. Frank and M. Pope 		773
38.1 Introduction 773
38.1.1 The Global AIDS Epidemic 773
38.1.2 Overview of Dendritic Cell Involvement in the Onset and Spread of HIV Infection 774
38.1.3 In vivo Evidence for DC Involvement in HIV Infection 776
38.1.3.1 Macaque Studies on Mucosal DCs and Infection 776
38.1.3.2 Changes in DC Biology in Immunodeficiency Virus Infection 777
38.2 Consequences of DC–HIV Interplay 778
38.2.1 HIV-binding Receptors Expressed by DCs 778
38.2.2 HIV Infection of DCs 780
38.2.3 Internalization of HIV Particles by DCs 782
38.3 DC-to-T-cell Transmission of Infectious Virus 783
38.3.1 Immunodeficiency Virus Replication in the DC–T Cell Milieu 783
38.3.2 Virus Movement across DC–T-cell Synapses 784
38.3.3 Two Phases of Virus Spread from DCs to T Cells 786
38.4 Inhibiting DC-driven Infection 788
38.4.1 Preventing direct HIV Interactions with DCs and DC–T-Cell Mixtures 788
38.4.2 DC-mediated HIV Transmission to T cells 789
38.5 Functional Modification of DCs by HIV Favors Infection over Immunity 790
38.5.1 Viral Factors Modify moDCs 790
38.5.2 Effects of Virus on Circulating DC Subsets 791
38.5.3 Virus-carrying Immature DCs Activate Substandard Virus-specific T-cell Responses 792
38.6 Implications for Vaccine and Microbicide Strategies 793
38.6.1 Blocking Mucosal Infection 793
38.6.2 Using DCs to Boost Immunity 794
38.6.2.1 DC-induced Primary Responses for Preventative HIV Vaccines 795
38.6.2.2 DC-based Therapeutic Control of Existing Immunodeficiency Virus Infection 796
38.7 Summary and Future Perspectives 797
Acknowledgements 797
References 797
39 Cytomegalovirus Infection of Dendritic Cells
Brigitte Sénéchal and James W. Young 		813
39.1 Introduction 813
39.2 HCMV Induces Immunosuppression 813
39.3 A Role for Dendritic Cells in the Pathology of CMV Infection 814
39.4 The Myeloid Lineage and Monocytes are Major Sites of HCMV Latency 814
39.5 Human Dendritic Cells are a Potential Target for HCMV 815
39.6 In vitro Evidence for HCMV Entry and Replication into Dendritic Cells 816
39.7 HCMV Impairs the Function of Immature Dendritic Cells 817
39.8 HCMV Impairs the Function of Mature Dendritic Cells 818
39.9 Langerhans-type Dendritic Cells are also Permissive to HCMV 819
39.10 Importance of Viral IL-10 in HCMV-induced Immunosuppression 820
39.11 CMV Infection of Dendritic Cells in the Mouse Model 820
39.12 Conclusion 822
Acknowledgements 823
References 823
40 Interactions of Hemorrhagic Fever Viruses with Dendritic Cells
Stefan Pöhlmann 		829
40.1 Introduction 829
40.2 Filoviruses 830
40.2.1 Pathology and Epidemiology 830
40.2.2 Replication 831
40.2.3 Tropism 832
40.2.4 Dendritic Cells are Major Targets of Ebolavirus 832
40.2.5 Filovirus Infection causes Aberrant Dendritic Cell Maturation 833
40.2.6 Filoviral Protein(s) Suppress Dendritic Cell Maturation 834
40.3 Dengue Virus (DEN) 835
40.3.1 Epidemiology and Pathology 835
40.3.2 Replication 836
40.3.3 Dengue Hemorrhagic Fever 836
40.3.4 Skin Dendritic Cells are Early Targets of Dengue Virus 837
40.3.5 Differential Effects of Dengue Virus on Infected and Bystander Dendritic Cells 837
40.4 Lassa Virus (LV) 839
40.5 Hantavirus (HTV) 840
40.6 Filoviruses and DEN Engage DC-SIGN, a Lectin Expressed on DCs 841
40.6.1 DC-SIGN – a Portal for Pathogens 841
40.6.2 Does DC-SIGN Promote Filovirus Infection in vivo? 842
40.6.3 DC-SIGNR – a DC-SIGN-related Attachment Factor that might Concentrate Filoviruses in Liver and Lymph Nodes 844
40.6.4 Dengue Virus Targets Dendritic Cells via DC-SIGN 844
40.7 Conclusions 845
Acknowledgements 846
Abbreviations 846
References 847
41 Dendritic Cells in Measles Virus Pathogenesis
Marion Abt, Nora Mueller and Sibylle Schneider-Schaulies 		855
41.1 General Introduction 855
41.2 The Virus: Structure and Genotypes 856
41.3 The Role of Entry Receptors in Measles Virus Pathogenesis 857
41.4 Dendritic Cells in Measles Virus Pathogenesis 859
41.4.1 Measles Virus Interaction with Receptors on Dendritic Cells and Functional Consequences 860
41.4.1.1 Interaction with Surface Receptors 860
41.4.1.2 Functional Consequences of Measles Virus Surface Interaction with Dendritic Cells 861
41.4.2 Impact of Measles Virus on Dendritic Cell Viability and Maturation 862
41.4.3 Impact of Measles Virus on External Maturation/Stimulation Signals in Dendritic Cells 863
41.4.4 Impact of Dendritic Cells Measles Virus Infection on T-cell Viability, Activation and Expansion 864
41.5 Conclusions and Perspectives 865
Acknowledgment 867
Abbreviations 868
References 868
42 Dendritic Cells and Herpes Simplex Virus Type 1
Alexander T. Prechtel and Alexander Steinkasserer 		875
42.1 The Herpes Simplex Virus Type 1 875
42.1.1 A Well-known Plaque for Centuries 875
42.1.2 The Role of Viral Immediate-early Proteins During the Conquest of the Cell 875
42.1.3 The Course of Herpes Simplex Virus Type 1 Infection and Replication 878
42.2 Herpes Simplex Virus meets Dendritic Cells 879
42.2.1 The Way into Dendritic Cells 879
42.2.1.1 Receptors and Ligands for Cell Entry 879
42.2.1.2 Infection of Different Dendritic Cell Populations by Herpes Simplex Virus Type 1 880
42.2.2 Interference with Typical Functions of Dendritic Cells 881
42.2.2.1 Interference with Dendritic Cell Maturation 881
42.2.2.2 Interference with Dendritic Cell Migration 882
42.2.2.3 Interference with Dendritic-cell-mediated T-cell Stimulation 884
42.3 The Cell Surface Molecule CD83 885
42.3.1 Characteristics of CD83 885
42.3.2 Modulation of Dendritic Cell Function by Interference with CD83 mRNA Processing 886
42.3.3 The Soluble Extracellular Domain of CD83 and its Influence on T-cell Proliferation 887
42.3.4 The Function of Membrane-bound CD83 887
42.3.5 Influence of CD83 on the T-cell Development in the Thymus 888
Acknowledgements 889
Abbreviations 889
References 889
43 Epstein–Barr Virus
Christian Münz 		897
43.1 The Epstein–Barr Virus (EBV) 897
43.2 Immune Control of Epstein–Barr Virus 898
43.3 Stimulation of Lymphocyte Compartments Relevant to Epstein–Barr Virus Immune Control in vitro 899
43.3.1 Tonsillar Natural Killer Cell Activation by Dendritic Cells and its Possible Role in Epstein–Barr Virus Infection 899
43.3.2 Initiation of Epstein–Barr Virus-specific T-cell Immunity by Dendritic Cells 900
43.4 Evidence for Priming of Epstein–Barr Virus Immune Control by Dendritic Cells in vivo 901
43.4.1 Strong Th1 Polarization of CD4+ T-cell Responses to the Nuclear Antigen 1 of Epstein–Barr Virus (EBNA1) 901
43.4.2 Priming of Epstein–Barr Virus-specific Responses by Crosspresentation via Dendritic Cells Leads to Heterogeneous Affinity of T-cell Responses 903
43.5 Detection of Epstein–Barr Virus Infection by the Immune System 903
43.6 Immunotherapeutic use of Dendritic Cells against Epstein–Barr Virus 904
43.7 Summary 905
References 906
XIV Fungi 915
44 Dendritic Cells in Immunity and Vaccination against Fungi
Luigina Romani and Paolo Puccetti 		915
44.1 Introduction 915
44.2 Immunity to Fungi 916
44.3 Dendritic Cells at the Host/Fungi Interface 917
44.3.1 Fungal Recognition by Dendritic Cells and Receptor Cooperativity 918
44.3.2 Dendritic Cell Activation 921
44.3.3 Dendritic Cell Conditioning 923
44.3.3.1 Opsonins 923
44.3.3.2 Tryptophan Metabolic Pathway 924
44.3.3.3 T-cell Ligands 925
44.3.3.4 Other Cells 925
44.4 Dendritic Cells Translate Fungus-associated Information to Th1, Th2 and Treg Cells 926
44.5 Exploiting Dendritic Cells as Fungal Vaccines 927
44.6 Conclusions and Perspectives 928
Acknowledgements 929
Abbreviations 929
References 930
XV Autoimmunity 935
45 Dendritic Cells in Autoimmune Diseases
Alexis Mathian, Sophie Koutouzov, Virginia Pascual, A. Karolina Palucka and Jacques Banchereau 		935
45.1 Introduction 935
45.2 Dendritic Cells 936
45.3 Dendritic Cells and Tolerance 936
45.3.1 Central Tolerance 936
45.3.2 Dendritic Cells and the Control of Peripheral Tolerance 938
45.4 Dendritic Cell Activation and the Priming of Autoimmune Diseases 939
45.4.1 Autoimmunity through Bystander Activation of Dendritic Cells 940
45.4.1.1 Systemic Lupus Erythematosus as an IFN-a Driven Disease 941
45.4.2 Defective Downregulation of Activated Dendritic Cells 942
45.4.3 The Rise of ”Autoimmune-prone” Dendritic Cell Subsets 942
45.5 Dendritic Cells Migrate into Inflammatory Sites and Maintain a Vicious Circle 945
45.6 Dendritic Cells: Failure to Maintain Peripheral Tolerance 946
45.7 A Special Role for Plasmacytoid Dendritic Cells in Systemic Lupus Erythemathosus 947
45.7.1 Plasmacytoid Dendritic Cells as the Main Producer of Type I IFN in Systemic Lupus Erythemathosus 948
45.7.2 Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation 948
45.8 Dendritic Cells Fail to Delete Developing Autoreactive T Cells 949
45.9 Autoimmunity Through Cytokine-induced Dendritic Cell Activation 949
45.10 Different Cytokines Generate Different Dendritic Cells that may lead to Different Autoimmune Syndromes 950
45.11 Concluding Remarks 951
Acknowledgements 951
References 952
XVI Transplantation 967
46 Role of Dendritic Cells in Graft Rejection and Graft-versus-host Disease
Véronique Flamand and Michel Goldman 		967
46.1 Alloantigen Presentation in Organ Transplantation 967
46.1.1 Pathways of Alloantigen Recognition 967
46.1.1.1 The Direct and Indirect Pathways 967
46.1.1.2 The Semi-direct Pathway 969
46.1.2 Sites of Alloantigen Presentation 970
46.1.3 Factors Inducing Dendritic Cell Maturation and Migration 971
46.1.3.1 Ischemia/reperfusion Injury 971
46.1.3.2 Links between Innate and Adaptive Immunity during Allograft Rejection 972
46.2 Alloantigen Presentation during Graft-versus-host Disease 973
46.2.1 Dual Impact of Alloreactive T Cells during Graft-versus-host Disease 973
46.2.2 Role of Host Dendritic Cells 974
46.2.2.1 Host Dendritic Cells in the Initiation and Effector Phases of Graft-versus-host Disease 974
46.2.2.2 Attempts to Eliminate Host Dendritic Cells 975
46.2.2.3 The Effects of Recipient Conditioning on Dendritic Cell Maturation 975
46.2.2.4 Reconstitution of Dendritic Cell ContentLAQ1L 976
46.2.3 Role of Donor Dendritic Cells 977
Acknowledgements 977
References 978
47 Dendritic Cells and Transplantation Tolerance
Paul J. Fairchild, Stephen F. Yates and Herman Waldmann 		983
47.1 The Expanding World of Transplantation 983
47.2 The Role of Dendritic Cells in Allograft Rejection 985
47.2.1 Direct Presentation of Alloantigen 985
47.2.2 Indirect Presentation of Alloantigen 986
47.2.3 The Semi-direct Pathway of Alloantigen Presentation 987
47.2.4 Pathways of Antigen Presentation during Cell Replacement Therapy 988
47.3 The Role of Dendritic Cells in Self-tolerance 989
47.3.1 A Cell Type with Two Persona 989
47.3.2 Dendritic Cell Subsets Devoted to Tolerance 990
47.3.2.1 Dendritic Cells Expressing CD8a 990
47.3.2.2 Plasmacytoid Dendritic Cells 991
47.3.2.3 ”Regulatory” Dendritic Cells 993
47.3.3 The Maturation Status of Dendritic Cells 994
47.3.3.1 Immature Dendritic Cells have an Enhanced Capacity to be Tolerogenic 994
47.3.3.2 Maturation of Dendritic Cells as a Trigger Point for Immunity 996
47.4 Exploitation of Dendritic Cells for Transplantation Tolerance 997
47.4.1 Central Deletion of Alloreactive T Cells 997
47.4.2 Peripheral Regulation of Alloreactive T Cells 1000
47.4.3 Reinforcing a Tolerogenic Phenotype by Genetic Modification 1001
47.5 Prospects for the Induction of Tolerance via the Indirect Pathway 1002
47.6 Immune Intervention in Cell Replacement Therapy 1005
47.6.1 Generation of Hematopoietic Stem Cells (HSC) for Mixed Chimerism 1005
47.6.2 Generation of Dendritic Cells for Tolerance Induction 1006
References 1008
48 Dendritic Cells, Immune Regulation and Transplant Tolerance
Giorgio Raimondi and Angus W. Thomson 		1017
48.1 Introduction 1017
48.2 Dendritic Cells and Initiation of the Rejection Response 1017
48.3 Direct versus Indirect Pathways of Allorecognition 1020
48.4 Dendritic Cells and Tolerance Induction 1021
48.5 Mechanisms underlying Dendritic-cell-induced T-cell Tolerance 1022
48.6 Dendritic Cells and the Control of Organ Transplant Outcome 1026
48.6.1 Dendritic Cell Manipulation for Tolerance Induction: Specific Culture Conditions 1027
48.6.2 Dendritic Cell Manipulation for Tolerance Induction: Pharmacological Manipulation 1027
48.6.3 Dendritic Cell Manipulation for Tolerance Induction: Genetic Engineering 1028
48.6.4 Use of Specific Dendritic Cell Subsets for Tolerance Induction 1029
48.6.5 Dendritic Cell Therapy: Targeting the Indirect Pathway 1031
48.6.6 Dendritic Cells and the Treatment of Chronic Rejection 1033
48.7 Dendritic Cells and Cellular Markers of Transplant Tolerance 1034
48.8 Toward Clinical Use of Dendritic-cell-based Therapies for Tolerance Induction: Critical Considerations and Future Challenges 1035
48.8.1 Dendritic Cell–T Cell Interaction 1035
48.8.2 Dendritic Cells and Treg: a Complex Inter-relationship 1036
48.8.3 Fingerprints of ”Tolerogenic” Dendritic Cells 1037
48.8.4 Dendritic Cells at the Crossroads of the Immune System 1037
48.9 Conclusions 1038
Acknowledgments 1038
References 1039
XVII Allergy, Asthma 1047
49 Nickel Presentation to T Cells in Contact Hypersensitivity
H. U. Weltzien, K. Gamerdinger and H.-J. Thierse 		1047
49.1 Introduction 1047
49.2 Molecular Basis of Nickel Presentation to Human T Cells 1048
49.2.1 CD4-positive T Cells 1048
49.2.2 CD8-positive T Cells and Non-HLA Restricted Nickel Presentation 1051
49.3 Nickel-Binding Proteins 1051
49.3.1 A Role for Carrier Proteins in Nickel Presentation 1051
49.3.2 Heatshock Proteins as Nickel Binders 1052
49.4 Concluding Remarks 1053
References 1055
50 Dendritic Cells in Asthma
Hamida Hammad and Bart N. Lambrecht 		1059
50.1 Introduction 1059
50.2 Asthma as a Th2 Driven Disorder 1059
50.3 Lung Dendritic Cell Subsets 1061
50.4 Function of Lung Dendritic Cells in Primary Immune Responses to Inhaled Antigen and Sensitization to Inhaled Allergen 1062
50.5 Is Tolerance Induction in the Lung a Property of Specialized Dendritic Cell Subsets? 1065
50.6 Accumulation of Mature Dendritic Cells in Ongoing Asthmatic Inflammation 1066
50.7 Direct Proof for a Functional Role for Dendritic Cells in Stimulating Effector Th2 Responses 1068
50.8 Determinants of Dendritic Cell Driven Th2 Responses in Asthma 1069
50.9 Dendritic Cells in Human Asthma 1071
50.10 Conclusion 1072
References 1073
XVIII Cancer 1081
51 Dendritic Cells in Human Cancer
Casey A. Carlos and Olivera J. Finn 		1081
51.1 Introduction 1081
51.2 Dendritic Cell Functions that are Important for Effective Immunity against Cancer 1082
51.3 Dendritic Cell Recognition of Malignant Changes in Tissues 1083
51.4 How Tumors Interfere with Normal Dendritic Cell Function 1084
51.4.1 Inhibition of Maturation and Differentiation 1084
51.4.2 Influence on Migration 1085
51.4.3 Suppression of Function 1086
51.5 Summary 1087
References 1088
Part C Therapeutical Applications of Dendritic Cells 1093
XIX Cancer 1095
52 Dendritic Cell Subsets as Targets and Vectors for Vaccination
Hideki Ueno, Joseph Fay, Jacques Banchereau and A. Karolina Palucka 		1095
52.1 Introduction 1095
52.2 Cancer Vaccines 1096
52.3 Dendritic Cells 1097
52.3.1 Dendritic Cell Subsets 1097
52.3.2 Distinct Dendritic Cell Subsets Induce Distinct Types of Immune Response 1099
52.3.3 Dendritic Cells and Immune Tolerance 1100
52.4 Dendritic Cells as Cancer Vaccines 1100
52.4.1 Dendritic Cell Subsets 1100
52.4.2 Dendritic Cell Maturation 1101
52.4.3 Dendritic Cell Migration 1102
52.4.4 Antigen Loading 1103
52.5 Regulatory/suppressor Mechanisms 1104
52.6 Immunological and Clinical Efficacy 1105
52.6.1 Immunological Efficacy 1105
52.6.2 Clinical Efficacy 1106
52.7 Conclusions 1107
Acknowledgements 1107
References 1107
53 Renal Cell Carcinoma
Martin Thurnher, Thomas Putz, Andrea Rahm, Hubert Gander, Reinhold Ramoner, Georg Bartsch, Lorenz Höltl and Claudia Falkensammer 		1117
53.1 Dendritic Cells and Cancer Immunosurveillance 1117
53.2 Renal Cell Carcinoma 1117
53.3 Immunotherapy of Renal Cell Carcinoma 1118
53.4 Dendritic Cell-based Immunotherapy of Renal Cell Carcinoma 1119
53.4.1 The Two-step Culture System 1119
53.4.2 Generation of Clinical Grade Dendritic Cells 1119
53.4.3 Clinical Trials of Dendritic Cells in Renal Cell Carcinoma Patients 1120
53.5 Adjuvant Immunotherapy of Organ Confined Renal Cell Carcinoma after Partial or Radical Nephrectomy 1122
53.6 Patient Selection in Future Trials 1123
53.7 Adverse Effects – Quality of Life 1123
53.8 Concluding Remarks 1124
Acknowledgements 1124
References 1124
XX Antigen Delivery 1129
54 Crosspresentation and Loading of Tumor Antigens for Dendritic Cell Vaccination against Cancer
Madhav V. Dhodapkar 		1129
54.1 Approaches to Antigen Loading for Dendritic-cell-mediated Immunotherapy 1129
54.2 Importance of Receptor-mediated Uptake to Crosspresentation 1130
54.3 Uptake of Dying Cells 1131
54.4 Uptake of Immune Complexes and Opsonized Pathogens and Tumor Cells 1131
54.5 Uptake of Heat Shock Protein–Peptide Complexes 1132
54.6 Exosomes as Sources of Multiple Tumor Antigens 1133
54.7 Role of C-type Lectin Receptors 1133
54.8 Other Routes of Antigen Entry for Crosspresentation 1133
54.9 Processing of the Antigenic Cargo 1134
54.10 Nature of the Antigenic Cargo 1134
54.11 Regulation of Crosspresentation during Dendritic Cell Maturation 1135
54.12 Role of Dendritic Cell Subsets in Crosspresentation 1136
54.13 Some Approaches to Improve Antigen Loading of Dendritic Cells for Clinical Vaccination 1136
54.14 Concluding Remarks 1137
References 1138
55 Nucleic Acid Transfer
Niels Schaft, Jan Dörrie and Dirk M. Nettelbeck 		1143
55.1 General Introduction 1143
55.2 Antigen Delivery to DC by Adenoviral Gene Transfer 1145
55.2.1 Recombinant Adenovirus as Gene Transfer Vector 1146
55.2.2 Adenoviral Gene Transfer into Dendritic Cells in Vitro 1149
55.2.3 Adenoviral Antigen Delivery to DC for Ex Vivo Tumor Vaccination in Mouse Tumor Models 1151
55.2.4 Adenoviral Ag Delivery for HIV/SIV Vaccination in Monkeys 1153
55.3 Antigen Delivery to DC by Transfection of Nucleic Acids 1154
55.3.1 Passive Pulsing 1155
55.3.2 Electroporation 1156
55.3.3 Lipofection 1159
55.4 Concluding Remarks 1160
References 1161
Subject Index 1173

 
Bestellen
Online-Ausgabe
Inhaltsverzeichnis
Kurzbeschreibung
Langtext
Autoreninformation
Sitz der Autoren

Weitere Bücher

Encyclopedia of Drug Metabolism and Interactions
6-Volume Set

Yeast
Molecular and Cell Biology

Systems Biology


[mehr >>]

Weitere Zeitschriften

Biologie in unserer Zeit

Pharmazie in unserer Zeit

Archiv der Pharmazie


[mehr>>]

Angebot

Krämer, Wolfgang / Schirmer, Ulrich / Jeschke, Peter / Witschel, Matthias (eds.)

Modern Crop Protection Compounds
449,- Euro
gültig bis
30. Juni 2012

[mehr Angebote >>]


 

        

Seite empfehlen          RSS-Feeds         Druckversion         Sitemap

©2012 Wiley-VCH Verlag GmbH & Co. KGaA - Betreiber
http://www.wiley-vch.de - mailto: info@wiley-vch.de
Datenschutz